This invention relates to novel carboxyl- or hydroxyl-substituted benzimidazole derivatives of formula (I)
wherein R
1
to R
6
are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds bind to FXR and can be used as medicaments.
这项发明涉及公式(I)中的新型羧基或羟基取代
苯并咪唑衍
生物,
其中R1至R6如描述和索赔中所定义,以及其生理上可接受的盐和
酯。这些化合物与FXR结合,可用作药物。